Anktiva

N-803 · ImmunityBio, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Anktiva, covering 2024-04-22 to 2026-06-12. Get the full timeline:

Most recent: EMA Authorised: Anktiva (nogapendekin alfa inbakicept) — Immunitybio Ireland Limited